Company Filing History:
Years Active: 2010-2014
Title: Juergen Mestan: Innovator in Pharmaceutical Combinations
Introduction
Juergen Mestan is a notable inventor based in Denzlingen, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative drug combinations for treating proliferative diseases. With a total of 3 patents to his name, Mestan's work has the potential to impact the medical community significantly.
Latest Patents
Mestan's latest patents include a pharmaceutical combination that features pyrimidylaminobenzamide compounds and imatinib for treating or preventing proliferative diseases. This invention provides a unique pharmaceutical combination comprising 4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-N-[5-(4-methyl-1H-imidazol-1-yl)-3-(trifluoromethyl)phenyl]-benzamide, specifically aimed at the treatment of melanoma. The present invention relates to the use of pyrimidylaminobenzamide compounds for preparing a drug that targets diseases responsive to modulation of Ephrin receptor kinase, particularly EphB4 activity. This innovative approach is designed for both curative and prophylactic treatment of proliferative diseases.
Career Highlights
Throughout his career, Juergen Mestan has worked with prominent companies in the pharmaceutical industry, including Novartis AG and Novartis Pharma GmbH. His experience in these organizations has allowed him to develop and refine his expertise in drug formulation and therapeutic applications.
Collaborations
Mestan has collaborated with notable professionals in his field, including Paul William Manley and Leila Alland. These partnerships have contributed to the advancement of his research and the successful development of his patented inventions.
Conclusion
Juergen Mestan's innovative work in pharmaceutical combinations showcases his dedication to improving treatment options for proliferative diseases. His contributions to the field are marked by his patents and collaborations, which highlight his role as a significant inventor in the pharmaceutical industry.